Show simple item record

dc.contributor.advisorFrance Leclerc.en_US
dc.contributor.authorLevine, Sharon B. (Sharon Beth)en_US
dc.date.accessioned2005-09-21T21:56:16Z
dc.date.available2005-09-21T21:56:16Z
dc.date.copyright1991en_US
dc.date.issued1991en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/13385
dc.descriptionThesis (M.S.)--Massachusetts Institute of Technology, Sloan School of Management, 1991.en_US
dc.descriptionIncludes bibliographical references (leaves 48-49).en_US
dc.description.statementofresponsibilityby Sharon B. Levine.en_US
dc.format.extent49 leavesen_US
dc.format.extent3071143 bytes
dc.format.extent3070903 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsM.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582
dc.subjectSloan School of Managementen_US
dc.titleMarketing phamaceuticals to a united Europe : the implications of 1992en_US
dc.typeThesisen_US
dc.description.degreeM.S.en_US
dc.contributor.departmentSloan School of Managementen_US
dc.identifier.oclc25378562en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record